All Insights
Showing 61 - 72 of 651
Regulatory Outlook
Cyber security | UK Regulatory Outlook January 2026
The Cyber Security and Resilience Bill | Cyber essentials supply chain playbook | Government cyber security strategy
Regulatory Outlook
Artificial intelligence | UK Regulatory Outlook January 2026
UK: AI and copyright | UK AI bill | EU: EU AI Act | Digital omnibus on AI | Labelling
Digital Regulation
Simplification for AI Medical Devices?
How the European Commission’s proposal on amending the MDR and IVDR adds to the simplification efforts by the Digital Omnibus
Life Sciences and Healthcare
EU revised device rules rebalance compliance towards simplification and proportionality
Commission proposal would streamline MDR and IVDR duties with flexible evidence, timeless certificates and tailored risk rules
Knowledge Notes
What business law changes can the UK expect in 2026?
Osborne Clarke's Knowledge Team looks at what's in store for business
Intellectual property
English court maintains anti-anti-suit relief and dismisses InterDigital's jurisdiction challenge
Case will proceed to a final RAND determination after the jurisdiction challenge dismissed, with interim relief to protect the proceedings
Financial Services
Six a day? FCA sets out reconciliation rules to address safeguarding risks for UK payment and e-money firms
Steps include both internal and external safeguarding tests and a second 'day after receipt' check
IT and data
UK Cyber Security and Resilience Bill: pragmatic overhaul or regulatory overload?
The key changes and action points for businesses, and how the bill compares with the EU NIS2
GDPR for HR
GDPR for HR | December 2025
Data subject access requests: the impact of AI, the Data (Use and Access) Act, and ICO enforcement
Digital Regulation
Digital Omnibus reshapes EU cookie rules but leaves banner fatigue largely intact
The Digital Omnibus Proposal promises a cleaner, GDPR-based framework for cookies and consent, yet its narrow exemptions and technical fixes
IT and data
The implementation of the NIS-2 Directive in Germany – What are the deviations from the NIS-2 Directive?
Germany’s NIS-2 Act is in force now narrowing scope and adding a ‘critical’ tier compared to the NIS-2 Directive. With
Life Sciences and Healthcare
Autumn Budget 2025: what does recent government policy mean for UK life sciences and healthcare?
Targeted R&D support and faster regulatory pathways will be boosted by landmark UK-US pharmaceuticals deal
